Suppr超能文献

精神分裂症的问题解决技巧。

Problem solving skills for schizophrenia.

作者信息

Xia J, Li Chunbo

机构信息

University of Leeds, Department of Psychiatry and Behavioural Sciences, 15-19 Hyde Terrace, Leeds, UK, LS2 9LT.

出版信息

Cochrane Database Syst Rev. 2007 Apr 18;2007(2):CD006365. doi: 10.1002/14651858.CD006365.pub2.

Abstract

BACKGROUND

The severe and long-lasting symptoms of schizophrenia are often the cause of severe disability. Environmental stress such as life events and the practical problems people face in their daily can worsen the symptoms of schizophrenia. Deficits in problem solving skills in people with schizophrenia affect their independent and interpersonal functioning and impair their quality of life. As a result, therapies such as problem solving therapy have been developed to improve problem solving skills for people with schizophrenia.

OBJECTIVES

To review the effectiveness of problem solving therapy compared with other comparable therapies or routine care for those with schizophrenia.

SEARCH STRATEGY

We searched the Cochrane Schizophrenia Group's Register (September 2006), which is based on regular searches of BIOSIS, CENTRAL, CINAHL, EMBASE, MEDLINE and PsycINFO. We inspected references of all identified studies for further trials.

SELECTION CRITERIA

We included all clinical randomised trials comparing problem solving therapy with other comparable therapies or routine care.

DATA COLLECTION AND ANALYSIS

We extracted data independently. For homogenous dichotomous data we calculated random effects, relative risk (RR), 95% confidence intervals (CI) and, where appropriate, numbers needed to treat (NNT) on an intention-to-treat basis. For continuous data, we calculated weighted mean differences (WMD) using a random effects statistical model.

MAIN RESULTS

We included only three small trials (n=52) that evaluated problem solving versus routine care, coping skills training or non-specific interaction. Inadequate reporting of data rendered many outcomes unusable. We were unable to undertake meta-analysis. Overall results were limited and inconclusive with no significant differences between treatment groups for hospital admission, mental state, behaviour, social skills or leaving the study early. No data were presented for global state, quality of life or satisfaction.

AUTHORS' CONCLUSIONS: We found insufficient evidence to confirm or refute the benefits of problem solving therapy as an additional treatment for those with schizophrenia. The small number of participants, the quality of reporting of methods and results were of concern. More trials with adequate reporting of methods to minimize bias, adequately powered, with validated, reliable and clinically meaningful outcomes are needed to provide robust evidence to guide policy and practice.

摘要

背景

精神分裂症严重且持久的症状往往是导致严重残疾的原因。诸如生活事件等环境压力以及人们在日常生活中面临的实际问题会加重精神分裂症的症状。精神分裂症患者解决问题能力的缺陷会影响他们的独立功能和人际交往功能,并损害他们的生活质量。因此,已经开发出诸如解决问题疗法等治疗方法来提高精神分裂症患者的解决问题能力。

目的

比较解决问题疗法与其他类似疗法或常规护理对精神分裂症患者的有效性。

检索策略

我们检索了Cochrane精神分裂症研究组注册库(2006年9月),该注册库基于对BIOSIS、CENTRAL、CINAHL、EMBASE、MEDLINE和PsycINFO的定期检索。我们检查了所有已识别研究的参考文献以寻找进一步的试验。

选择标准

我们纳入了所有将解决问题疗法与其他类似疗法或常规护理进行比较的临床随机试验。

数据收集与分析

我们独立提取数据。对于同质二分数据,我们基于意向性分析计算随机效应、相对风险(RR)、95%置信区间(CI),并在适当情况下计算治疗所需人数(NNT)。对于连续数据,我们使用随机效应统计模型计算加权平均差(WMD)。

主要结果

我们仅纳入了三项小型试验(n = 52),这些试验评估了解决问题疗法与常规护理、应对技能训练或非特异性互动的对比。数据报告不充分使得许多结果无法使用。我们无法进行荟萃分析。总体结果有限且无定论,治疗组在住院、精神状态、行为、社交技能或提前退出研究方面没有显著差异。未提供关于整体状态、生活质量或满意度的数据。

作者结论

我们发现没有足够的证据来证实或反驳解决问题疗法作为精神分裂症患者附加治疗方法的益处。参与者数量少、方法和结果的报告质量令人担忧。需要更多试验,充分报告方法以尽量减少偏倚,具备足够的样本量,采用经过验证、可靠且具有临床意义的结果,以提供有力证据来指导政策和实践。

相似文献

1
Problem solving skills for schizophrenia.
Cochrane Database Syst Rev. 2007 Apr 18;2007(2):CD006365. doi: 10.1002/14651858.CD006365.pub2.
2
Sertindole for schizophrenia.
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.
3
Selective noradrenaline reuptake inhibitors for schizophrenia.
Cochrane Database Syst Rev. 2018 Jan 25;1(1):CD010219. doi: 10.1002/14651858.CD010219.pub2.
4
Aripiprazole for schizophrenia.
Cochrane Database Syst Rev. 2006 Apr 19;2006(2):CD004578. doi: 10.1002/14651858.CD004578.pub3.
5
Early intervention for psychosis.
Cochrane Database Syst Rev. 2006 Oct 18(4):CD004718. doi: 10.1002/14651858.CD004718.pub2.
6
Lithium for schizophrenia.
Cochrane Database Syst Rev. 2007 Jul 18(3):CD003834. doi: 10.1002/14651858.CD003834.pub2.
7
Risperidone versus olanzapine for schizophrenia.
Cochrane Database Syst Rev. 2006 Apr 19(2):CD005237. doi: 10.1002/14651858.CD005237.pub2.
8
Cognitive behavioural therapy (group) for schizophrenia.
Cochrane Database Syst Rev. 2022 Jul 12;7(7):CD009608. doi: 10.1002/14651858.CD009608.pub2.
9
Risperidone versus olanzapine for schizophrenia.
Cochrane Database Syst Rev. 2005 Apr 18(2):CD005237. doi: 10.1002/14651858.CD005237.
10
Mirtazapine adjunct for people with schizophrenia.
Cochrane Database Syst Rev. 2018 May 26;5(5):CD011943. doi: 10.1002/14651858.CD011943.pub2.

引用本文的文献

2
Social cognition and emotional rehabilitation in participants with schizofrenia.
Front Psychiatry. 2023 Nov 8;14:1250933. doi: 10.3389/fpsyt.2023.1250933. eCollection 2023.
3
Measuring the digital divide among people with severe mental ill health using the essential digital skills framework.
Perspect Public Health. 2024 Jan;144(1):21-30. doi: 10.1177/17579139221106399. Epub 2022 Aug 5.
6
Chinese herbal medicines for treating skin and soft-tissue infections.
Cochrane Database Syst Rev. 2014 Jul 25;2014(7):CD010619. doi: 10.1002/14651858.CD010619.pub2.

本文引用的文献

1
Neurocognitive and symptom correlates of daily problem-solving skills in schizophrenia.
Schizophr Res. 2006 Apr;83(2-3):237-45. doi: 10.1016/j.schres.2005.12.849. Epub 2006 Jan 27.
3
Family intervention for schizophrenia.
Cochrane Database Syst Rev. 2003(4):CD000088. doi: 10.1002/14651858.CD000088.
4
Measuring inconsistency in meta-analyses.
BMJ. 2003 Sep 6;327(7414):557-60. doi: 10.1136/bmj.327.7414.557.
5
The impact of cognitive remediation on psychiatric symptoms of schizophrenia.
Schizophr Res. 2003 Oct 1;63(3):229-35. doi: 10.1016/s0920-9964(02)00374-2.
6
An evaluation of a stress management program for individuals with schizophrenia.
Schizophr Res. 2002 Dec 1;58(2-3):293-303. doi: 10.1016/s0920-9964(01)00371-1.
7
Issues in the meta-analysis of cluster randomized trials.
Stat Med. 2002 Oct 15;21(19):2971-80. doi: 10.1002/sim.1301.
8
An evaluation of a six-week intervention designed to facilitate coping with psychological stress.
J Clin Psychol. 2001 Dec;57(12):1381-401. doi: 10.1002/jclp.1104.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验